University of California, Irvine at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

University of California, Irvine takes part in 10 sessions at CTAD 2026 in Boston. Its program centres on trial design and early detection, including Alzheimer's disease in Down syndrome. Its work covers digital memory tasks for preclinical disease, adaptive trial designs and attitudes toward research participation.

OrganizationCTAD 2026 Attendance
Universities & institutes
Its Institute for Memory Impairments and Neurological Disorders (UCI MIND) runs Alzheimer's research, including Down syndrome studies.
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue
Poster
Thu Nov 19
7:15am–5:00pm
Digital Cognitive Signatures of Biomarker-Defined Preclinical Alzheimer’s Disease (P433)
Digital assessment and AI · Prevention and early disease · Rising Stars Showcase
Poster
Thu Nov 19
7:15am–5:00pm
The Effect of Messaging on Research Enrollment (P500)
Trial design and endpoints

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of California, Irvine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction